Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison
ABSTRACT Background Androgen receptor signaling inhibitors (ARSI) combined with androgen deprivation therapy (ADT) have demonstrated significant survival benefits in metastatic hormone‐sensitive prostate cancer (mHSPC) in several clinical trials. However, data specifically in Asian patients remain l...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2026-02-01
|
| Col·lecció: | Cancer Reports |
| Accés en línia: | https://doi.org/10.1002/cnr2.70496 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|